Fibromyalgia incidence among patients with hepatitis B infection
| Autor: | Mahmut Alpayci, Davut İpek, Tahsin Çelepkolu, Özcan Deveci, Levent Yazmalar, İbrahim Batmaz, Dicle Akdeniz, Mustafa Akif Sariyildiz, Erkam Hattapoğlu |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male medicine.medical_specialty HBsAg Fibromyalgia Turkey Visual analogue scale medicine.disease_cause Gastroenterology 03 medical and health sciences Hepatitis B Chronic 0302 clinical medicine Rheumatology Internal medicine medicine Humans 030212 general & internal medicine reproductive and urinary physiology 030203 arthritis & rheumatology Hepatitis B virus Sleep disorder Hepatitis B Surface Antigens business.industry Incidence Incidence (epidemiology) virus diseases hemic and immune systems Middle Aged Hepatitis B medicine.disease biological factors digestive system diseases Surgery Anti-Retroviral Agents Case-Control Studies embryonic structures Female business Body mass index Biomarkers |
| Zdroj: | International Journal of Rheumatic Diseases. 19:637-643 |
| ISSN: | 1756-1841 |
| DOI: | 10.1111/1756-185x.12593 |
| Popis: | Aim The purpose of our investigation was to evaluate the incidence of fibromyalgia syndrome (FMS) and identify FMS-related clinical symptoms in hepatitis B virus (HBV) patients. Methods One hundred and eighteen HBV surface antigen (HbsAg)-positive patients (40 with chronic active hepatitis B, 40 hepatitis B carriers and 38, all of whom had been antiretroviral-treated for at least 3 months) were included in this study. In addition, 60 age- and gender-matched HbsAg-negative healthy controls were included in the study. Results There was no significant difference in age, gender or body mass index (BMI) between the two groups (P > 0.05). Serum aspartate aminotransferase and alanine aminotransferase levels were significantly higher in HBV patients relative to the control group (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text